Join the 'Gordochom' group to help and get support from people like you.
Posted 25 Nov 2015 by Drugs.com
WEDNESDAY, Nov. 25, 2015 – Patients using prescription creams, gels, sprays and pills for skin conditions may shell out substantially more at the pharmacy than they did just six years ago, a new study suggests. Between 2009 and 2015, retail prices of brand-name dermatologic drugs rose 401 percent, on average, study authors reported Nov. 25 in JAMA Dermatology. Even generics have succumbed to price inflation, up 279 percent between 2011 and 2014, based on the drugs surveyed. Price increases for skin treatments far outpaced the general inflation rate of 11 percent during the six-year study period, the researchers said. "Cancer drugs were the worst in terms of the numbers" – up 1,240 percent or nearly $11,000 over the six-year study period – primarily because of two medicines, said Dr. Steven Rosenberg, voluntary professor of dermatology at the University of Miami Miller School of ... Read more
Related support groups: Monistat, RID, Monistat 3, Eczema, Monistat 7, Voltaren Gel, Dermatitis, Clobetasol, Contact Dermatitis, Mupirocin, Bactroban, Therapeutic, Efudex, Maintain, Sulfur, Drysol, Hypercare, Epiduo, Retin-A, Fluocinonide
Posted 1 Jul 2015 by Drugs.com
WEDNESDAY, July 1, 2015 – The prescription drops your child is using for ear pain could be among 16 unapproved medications targeted this week by the U.S. Food and Drug Administration. These drugs, prescribed and sold for years to relieve ear pain and swelling, have not been evaluated for safety, quality and effectiveness, the agency said Wednesday. The agency notified the drugs' makers to stop marketing the drops following a few reports of local allergic reactions of the ear, eye, face, neck and mouth. The drops can also cause itching, stinging, burning and irritation of the ear, according to an FDA news release. "If we don't know whether these drugs have any benefits, we should not accept any possible risk of side effects," said the FDA's Dr. Charles Lee in the news release. The FDA did not release the names of the companies or the medications involved, but did note that "unapproved ... Read more
Related support groups: Otitis Media, Maintain, Orajel, Benzocaine, Pramoxine, Anbesol, Anusol, Vagisil, Analpram-HC, Hydrocortisone/Pramoxine, Lanacane, Allergen, Caladryl, Antipyrine/Benzocaine, Zilactin Toothache, Galzin, Dendracin, Caladryl Clear, Otitis Externa, Solarcaine